Two New FDA-Approved Treatments for RKD

FILSPARI® (sparsentan) has been FDA approved for FSGS, and TRUTAKNA® (atacicept) has been FDA approved for IgAN. More information is coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Contact This Study

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.